- Cessation of spread as a treatment objective in vitiligo: perception from the patients' point of view
- The many faces of IL-17 in inflammatory skin diseases
- Galectin-3 in renal pathology: more than just an innocent bystander?
- Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo
Pyoderma gangrenosum with granuloma formation: not always a benign disorder
2016) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 30(1). p.188-189 Mark(